Your browser doesn't support javascript.
loading
Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity
MEAJO-Middle East African Journal of Ophthalmology. 2010; 17 (3): 264-267
en Inglés | IMEMR | ID: emr-123602
ABSTRACT
This study was designed to present our early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity [ROP] at a single institution over a 13-month-period. A retrospective case series of eight children with ROP who received intravitreal bevacizumab combined with laser treatment between June 2007 and July 2008 were reported. A chart review was conducted to evaluate if stability of the ROP lesions had been achieved. Main information collected included data on demographics, gestational age, birth weight, length of stay in neonatal intensive care unit, and stage of ROP. Fifteen eyes of eight subjects were treated. One eye did not receive any treatment due to complete retinal detachment. The median age at treatment was 8 weeks [range, 6 weeks to 1 year]. The most common stage of ROP was 3+. All eyes remained stable at 1 year or later after treatment. Intravitreal bevacizumab in conjunction with laser treatment had promising results at our institution. We recommend prospective, randomized, controlled clinical trials to compare the effects of laser treatment alone, of bevacizumab treatment alone [at different doses], and of combined bevacizumab and laser treatment
Asunto(s)
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Cuerpo Vítreo / Estudios Retrospectivos / Factor A de Crecimiento Endotelial Vascular / Terapia por Láser / Anticuerpos Monoclonales Tipo de estudio: Ensayo Clínico Controlado Límite: Femenino / Humanos / Masculino Idioma: Inglés Revista: Middle East Afr. J. Ophthalmol. Año: 2010

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Cuerpo Vítreo / Estudios Retrospectivos / Factor A de Crecimiento Endotelial Vascular / Terapia por Láser / Anticuerpos Monoclonales Tipo de estudio: Ensayo Clínico Controlado Límite: Femenino / Humanos / Masculino Idioma: Inglés Revista: Middle East Afr. J. Ophthalmol. Año: 2010